| Symbol | IART |
|---|---|
| Name | INTEGRA LIFESCIENCES HOLDINGS CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 1100 CAMPUS ROAD, PRINCETON, NJ 08540 |
| Telephone | 6092750500 |
| Fax | — |
| — | |
| Website | https://www.integralife.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000917520 |
| Description | Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopaedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopaedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific and the rest of the world whilst it derives key revenue from domestic sales. Additional info from NASDAQ: |
2026-05-15 12:49
New Form SCHEDULE 13G - INTEGRA LIFESCIENCES HOLDINGS CORP <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001037792-26-000009 <b>Size:</b> 6 KB
Read more
2026-05-11 20:41
Director HILL BARBARA B 🟢 acquired 24.3K shares of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: May 07, 2026 | Filing ID: 000001
Read more
2026-05-11 20:40
Director BRADLEY KEITH 🟡 adjusted position in 16.8K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) at $13.92 Transaction Date: May 07, 2026 | Filing ID: 000001
Read more
2026-05-11 20:39
Director Clay Shaundra 🟢 acquired 17.7K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: May 07, 2026 | Filing ID: 000001
Read more
2026-05-11 20:38
Director GRAVES JEFFREY A 🟢 acquired 17.7K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: May 07, 2026 | Filing ID: 000011
Read more
2026-05-11 20:38
Director Lo Renee Wonlai 🟢 acquired 17.7K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: May 07, 2026 | Filing ID: 000001
Read more
2026-05-11 20:37
Director SCHADE CHRISTIAN S 🟢 acquired 17.7K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: May 07, 2026 | Filing ID: 000001
Read more
2026-05-08 17:46
New Form S-8 - INTEGRA LIFESCIENCES HOLDINGS CORP <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0000917520-26-000046 <b>Size:</b> 331 KB
Read more
2026-05-08 12:00
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Read more
2026-05-05 10:20
(99% Neutral) INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Reports Q2 2026 Financial Results
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07071298 | AERA Pediatrics Registry | — | Dysfunction of Eustachian Tube | Recruiting | 2025-06-17 | 2031-02-01 | ClinicalTrials.gov |
| NCT06760611 | Tissue Quality of Integra vs. BTM Treated Burns | — | Burn Injury | Withdrawn | 2025-03-01 | 2025-09-30 | ClinicalTrials.gov |
| NCT06629506 | MicroMatrix® Flex in Tunneling Wounds | Na | Pressure Injury | Completed | 2024-12-12 | 2025-08-31 | ClinicalTrials.gov |
| NCT06453187 | A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot… | Na | Diabetic Foot Ulcer | Enrolling_By_Invitation | 2024-11-18 | 2027-03-31 | ClinicalTrials.gov |
| NCT06276543 | Bactiseal Catheter Safety Registry Study | — | Hydrocephalus | Recruiting | 2024-09-29 | 2026-12-31 | ClinicalTrials.gov |
| NCT06297187 | Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study | — | Vulvar Intraepithelial Neoplasia | Completed | 2024-02-23 | 2024-08-31 | ClinicalTrials.gov |
| NCT04459806 | Intracranial PrEssure Time dOse (ImPETO) | — | Intracranial Hypertension | Recruiting | 2023-11-13 | 2026-12-31 | ClinicalTrials.gov |
| NCT06034652 | T-GENVIH-003 LTFU (Long Term Follow Up) Study | — | Hernia | Completed | 2023-09-12 | 2024-01-19 | ClinicalTrials.gov |
| NCT05842057 | Human Amnion Membrane Allograft and Early Return of Erectile Function After Rad… | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2023-08-24 | 2028-08-31 | ClinicalTrials.gov |
| NCT04300075 | The CUSA Clarity Bone Tip Study | — | Cranial Skull Base Bone Removal | Withdrawn | 2023-06-01 | 2024-08-01 | ClinicalTrials.gov |
| NCT05652296 | External Ventricular Drainage Post-Market Clinical Follow-up Registry | — | Cerebrospinal; Disorder | Completed | 2023-03-03 | 2024-12-16 | ClinicalTrials.gov |
| NCT05397106 | Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve | — | Hydrocephalus | Active_Not_Recruiting | 2023-01-24 | 2029-01-24 | ClinicalTrials.gov |
| NCT05610267 | Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair | — | Ventral Hernia | Completed | 2022-11-22 | 2022-12-28 | ClinicalTrials.gov |
| NCT05311124 | Direct Application of Integra Bilayer Matrices on Bare Calvarium Without Prelim… | Na | Wound Care | Unknown | 2022-08-01 | 2023-10-01 | ClinicalTrials.gov |
| NCT05182177 | The SurgiMend PRS Retrospective Study | — | Reconstructive Surgical Procedures | Completed | 2022-01-31 | 2024-12-31 | ClinicalTrials.gov |
| NCT05113381 | The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is E… | Na | Intraventricular Hemorrhage | Completed | 2021-09-15 | 2025-07-31 | ClinicalTrials.gov |
| NCT05024656 | AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers | Na | Diabetic Foot Ulcer | Withdrawn | 2021-09-01 | 2024-06-01 | ClinicalTrials.gov |
| NCT04494295 | The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation | — | Supratentorial Hemorrhage | Recruiting | 2020-10-23 | 2029-10-15 | ClinicalTrials.gov |
| NCT04233580 | Characterization of AmnioExcel Plus in Two Treatment Paradigms | Na | Diabetic Foot Ulcer | Completed | 2020-07-09 | 2021-04-06 | ClinicalTrials.gov |
| NCT04285489 | A Study on the Safety of Hakim Programmable Shunt System | — | Hydrocephalus | Completed | 2020-05-02 | 2020-07-28 | ClinicalTrials.gov |
| NCT04282720 | SurgiMend Mesh at the Hiatus | Na | Hiatal Hernia | Completed | 2020-03-31 | 2023-09-05 | ClinicalTrials.gov |
| NCT04298268 | The CUSA Clarity Soft Tissue Removal Study | — | Benign, Malignant Tumors or Other Soft Tissue Removal | Completed | 2020-03-30 | 2021-11-24 | ClinicalTrials.gov |
| NCT04207229 | CERTAS Programmable Valve Registry | — | Hydrocephalus | Completed | 2019-11-21 | 2021-11-18 | ClinicalTrials.gov |
| NCT03626623 | Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of C… | Na | Diabetes | Terminated | 2019-05-21 | 2020-02-18 | ClinicalTrials.gov |
| NCT03816202 | Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF) | — | Carotid Artery Stenosis | Completed | 2019-04-25 | 2019-08-27 | ClinicalTrials.gov |
| NCT04041037 | The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Mat… | — | Pilonidal Disease | Terminated | 2019-03-26 | 2019-11-05 | ClinicalTrials.gov |
| NCT03317665 | Observational Biologic or Prosthetic Mesh | — | Ventral Incisional Hernia | Terminated | 2019-02-11 | 2021-06-11 | ClinicalTrials.gov |
| NCT03632954 | Cytal® Wound Matrix and MicroMatrix® Wound Study | — | Wounds | Terminated | 2018-12-11 | 2020-01-27 | ClinicalTrials.gov |
| NCT03598023 | A Study to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Par… | Na | Partial Thickness Burn of Hand | Withdrawn | 2018-08-01 | 2020-12-31 | ClinicalTrials.gov |
| NCT03350750 | A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | Na | Idiopathic Normal Pressure Hydrocephalus (INPH) | Completed | 2018-05-21 | 2021-05-18 | ClinicalTrials.gov |
| NCT03547635 | AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic … | Na | Diabetic Foot Ulcer | Completed | 2018-05-03 | 2019-02-26 | ClinicalTrials.gov |
| NCT04543240 | Bacterial Load for Integra™ in Operative Wounds | — | Wounds and Injuries | Unknown | 2017-12-14 | 2021-01-01 | ClinicalTrials.gov |
| NCT03034213 | Gentrix™ Versus Biological or Prosthetic Mesh | Na | Ventral Incisional Hernia | Terminated | 2017-10-06 | 2021-06-16 | ClinicalTrials.gov |
| NCT03283787 | Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of… | Na | Pressure Ulcers Stage III | Completed | 2017-04-01 | 2019-12-23 | ClinicalTrials.gov |
| NCT02767492 | Steroid Injection vs. BioDRestore for Patients With Knee OA | Na | Knee Osteoarthritis | Completed | 2017-01-01 | 2020-01-01 | ClinicalTrials.gov |
| NCT03058731 | ACELL Mesh for Paraesophageal Hernia Repair | — | Paraesophageal Hernia | Completed | 2016-02-02 | 2019-01-28 | ClinicalTrials.gov |
| NCT02396745 | TECR & ECM Placement for Esophageal High Grade Dysplasia | Na | Barrett Esophagus | Terminated | 2016-01-25 | 2018-03-22 | ClinicalTrials.gov |
| NCT01840085 | Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC… | Phase3 | Diabetic Foot Ulcer | Terminated | 2015-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02750280 | A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the T… | Na | Neuropathic Diabetic Foot Ulcer | Completed | 2015-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02632929 | Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue | — | Diabetic Foot Ulcer | Completed | 2015-05-30 | 2019-09-30 | ClinicalTrials.gov |
| NCT02330159 | Feasibility of a Novel Technique for Pilonidal Wound Healing | — | Pilonidal Disease | Unknown | 2015-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02347943 | Global Sinus Surgery Registry | — | Chronic Rhinosinusitis | Terminated | 2015-01-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT03956316 | Short-Term Outcomes of Total Shoulder Arthroplasty Using the Titan Modular Tota… | — | Shoulder Disease | Completed | 2014-10-15 | 2015-12-22 | ClinicalTrials.gov |
| NCT02225080 | Duragen® Secure Post Marketing Clinical Follow-up (PMCF) | — | Dura Mater Nick Cut or Tear | Completed | 2014-10-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02557906 | Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M) | Na | Breast Neoplasms | Unknown | 2014-07-01 | 2020-01-01 | ClinicalTrials.gov |
| NCT02209051 | Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers | Na | Diabetic Foot Ulcers | Completed | 2014-07-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02250183 | Medihoney and Santyl for Burn Injuries | Na | Burns | Terminated | 2014-03-15 | 2016-08-18 | ClinicalTrials.gov |
| NCT02087150 | Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter | Na | Eustachian Tube Dysfunction | Completed | 2014-02-01 | 2017-01-12 | ClinicalTrials.gov |
| NCT01970306 | Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degra… | Phase2 | Esophageal Adenocarcinoma | Completed | 2013-10-18 | 2023-02-24 | ClinicalTrials.gov |
| NCT01947387 | Retrospective Study Evaluating Outcomes for Integra® Skin Sheet Products in Low… | — | Complex Lower Extremity Soft Tissue Reconstruction | Completed | 2013-08-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01858545 | A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers | Na | Foot Ulcer, Diabetic | Terminated | 2013-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01849965 | Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle an… | Phase3 | Diabetic Foot Ulcers | Terminated | 2013-04-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01830348 | Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulce… | Phase3 | Diabetic Foot Ulcers | Terminated | 2013-02-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01824706 | Prospective, Multicenter Observational Study Evaluating the Long Term Safety of… | — | Surgery | Completed | 2012-12-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01714687 | Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurr… | Na | Recurrent Acute Rhinosinusitis | Completed | 2012-10-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01611246 | Earset Healthy Volunteer Study | — | Otitis Media | Completed | 2012-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01455948 | Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment i… | Na | Chronic Rhinosinusitis | Terminated | 2012-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01496287 | Tympanostomy Tube Placement in Children in the Office (Inova Study) | Na | Otitis Media | Completed | 2011-12-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01444391 | inVENT-visIOn Study | Na | Otitis Media | Completed | 2011-10-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01346332 | Healthy Volunteer Study | — | Anesthesia of Tympanic Membrane | Completed | 2011-04-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01324271 | inVENT-In-Office Study | Na | Otitis Media | Completed | 2011-01-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01270633 | A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foo… | Na | Foot Ulcer, Diabetic | Terminated | 2010-12-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT01202578 | Evaluation of the Tympanostomy Tube Delivery System | Phase2 | Otitis Media With Effusion | Completed | 2010-09-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01060670 | A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Tr… | Na | Neuropathic Diabetic Ulcer - Foot | Completed | 2010-04-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01107379 | Optimization and Refinement of Technique in In-Office Sinus Dilation 2 | — | Sinusitis | Completed | 2010-04-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT02150044 | Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requi… | Na | Otitis Media | Completed | 2010-02-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01002287 | An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Foll… | Na | Ulcerative Colitis | Terminated | 2009-10-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00892333 | Large Abdominal Hernia Repair With SurgiMend 3.0 | — | Hernia | Completed | 2009-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00939796 | Clinical Study of the Tympanostomy Tube Delivery System | Na | Otitis Media With Effusion | Completed | 2009-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01046877 | Singapore Tympanostomy Tube Delivery System Study | Na | Otitis Media | Completed | 2008-12-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00891657 | Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy | Na | Fibroid | Completed | 2008-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00796744 | Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers | Phase2 | Foot Ulcer, Diabetic | Completed | 2008-10-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00748124 | PleuraSeal Pivotal Study (US) | Phase3 | Open Thoracotomy | Terminated | 2008-08-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00791934 | Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of T… | Na | Sinusitis | Completed | 2008-08-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00939393 | Balloon Sinus Dilation In Office or OR | Na | Chronic Sinusitis | Completed | 2008-04-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01228500 | The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospe… | Na | Foot Ulcer, Diabetic | Withdrawn | 2008-01-01 | — | ClinicalTrials.gov |
| NCT02369497 | Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study | — | Arthritis | Terminated | 2007-12-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00444067 | Study to Evaluate Safety & Effectiveness of Spinal Sealant | Na | Cerebrospinal Fluid Leakage, Subdural | Completed | 2007-05-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT01054703 | Clinical Evaluation of the Ethmoid Sinus Spacer | Na | Sinusitis, Chronic Rhinosinusitis | Terminated | 2007-04-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00439309 | Study to Evaluate Safety & Effectiveness of Vascular Sealant System | Na | Peripheral Vascular Disease | Terminated | 2007-04-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00594035 | Study to Evaluate Safety and Effectiveness of Spinal Sealant | Na | Spinal Procedure Requiring Dura Incision | Completed | 2005-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00704340 | DuraSeal Sealant Post Market Study | Na | Elective Cranial Procedures With Dural Incision | Completed | 2005-09-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00231062 | Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranas… | Phase3 | Chronic Sinusitis | Completed | 2005-04-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00246792 | Enhancing Self-Understanding and Social Integration of Middle School Students W… | Phase2 | Learning Disability | Unknown | 2004-09-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00374114 | A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modalit… | Na | Cervical Dysplasia | Completed | 2004-01-01 | 2006-12-01 | ClinicalTrials.gov |
Total clinical trials: 85
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| ultrasonic surgical aspiration of the cervix | Other | Approved | Cervical Dysplasia | COMPLETED | NCT00374114 |
| cervical conization | Other | Approved | Cervical Dysplasia | COMPLETED | NCT00374114 |
| Standard Tissue Closure Techniques | Other | Phase PHASE3 | Open Thoracotomy | TERMINATED | NCT00748124 |
| PleuraSeal Sealant System | Other | Phase PHASE3 | Open Thoracotomy | TERMINATED | NCT00748124 |
| Standard Tissue Closure Techniques | Other | Phase PHASE3 | Open Thoracotomy | TERMINATED | NCT00748124 |
| PleuraSeal Sealant System | Other | Phase PHASE3 | Open Thoracotomy | TERMINATED | NCT00748124 |
| HRA | Other | Preclinical | Arthritis | TERMINATED | NCT02369497 |
| Standard of Care gel, Aquasite | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01849965 |
| placebo vehicle gel | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01849965 |
| DSC127 | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01849965 |
| 0.03% DSC127 topical gel | Other | Phase PHASE3 | Diabetic Foot Ulcer | TERMINATED | NCT01840085 |
| 0.03% DSC127 topical gel | Other | Phase PHASE3 | Diabetic Foot Ulcer | TERMINATED | NCT01840085 |
| Hakim Shunt Programmable System | Other | Preclinical | Hydrocephalus | COMPLETED | NCT04285489 |
| Good Surgical Technique Alone | Other | Approved | Ulcerative Colitis | TERMINATED | NCT01002287 |
| SprayShield Adhesion Barrier System | Other | Approved | Ulcerative Colitis | TERMINATED | NCT01002287 |
| Good Surgical Technique Alone | Other | Approved | Ulcerative Colitis | TERMINATED | NCT01002287 |
| SprayShield Adhesion Barrier System | Other | Approved | Ulcerative Colitis | TERMINATED | NCT01002287 |
| Novel Wound Healing Protocol | Other | Preclinical | Pilonidal Disease | UNKNOWN | NCT02330159 |
| Mepilex® [Silicone foam dressing] | Other | Approved | Neuropathic Diabetic Foot Ulcer | COMPLETED | NCT02750280 |
| MatriStem® [Urinary Bladder Matrix (UBM)] | Other | Approved | Neuropathic Diabetic Foot Ulcer | COMPLETED | NCT02750280 |
| Mepilex® [Silicone foam dressing] | Other | Approved | Neuropathic Diabetic Foot Ulcer | COMPLETED | NCT02750280 |
| MatriStem® [Urinary Bladder Matrix (UBM)] | Other | Approved | Neuropathic Diabetic Foot Ulcer | COMPLETED | NCT02750280 |
| PriMatrix | Other | Approved | Foot Ulcer, Diabetic | WITHDRAWN | NCT01228500 |
| Conventional Wound Therapy | Drug | Approved | Neuropathic Diabetic Ulcer - Foot | COMPLETED | NCT01060670 |
| Integra® Dermal Regeneration Template | Other | Approved | Neuropathic Diabetic Ulcer - Foot | COMPLETED | NCT01060670 |
| SprayShield™ | Other | Approved | Fibroid | COMPLETED | NCT00891657 |
| SprayShield™ | Other | Approved | Fibroid | COMPLETED | NCT00891657 |
| Standard of care | Other | Approved | Spinal Procedure Requiring Dura Incision | COMPLETED | NCT00594035 |
| Spinal Sealant System | Other | Approved | Spinal Procedure Requiring Dura Incision | COMPLETED | NCT00594035 |
| VascuSeal | Other | Approved | Peripheral Vascular Disease | TERMINATED | NCT00439309 |
| Gelfoam/Thrombin | Other | Approved | Peripheral Vascular Disease | TERMINATED | NCT00439309 |
| Standard of Care, Diabetic Foot Ulcers | Other | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02209051 |
| AMNIOEXCEL | Other | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02209051 |
| Standard of Care | Other | Approved | Foot Ulcer, Diabetic | TERMINATED | NCT01270633 |
| PriMatrix | Other | Approved | Foot Ulcer, Diabetic | TERMINATED | NCT01270633 |
| Standard of Care | Other | Approved | Foot Ulcer, Diabetic | TERMINATED | NCT01270633 |
| PriMatrix | Other | Approved | Foot Ulcer, Diabetic | TERMINATED | NCT01270633 |
| placebo vehicle gel | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01830348 |
| DSC127 | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01830348 |
| placebo vehicle gel | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01830348 |
| DSC127 | Other | Phase PHASE3 | Diabetic Foot Ulcers | TERMINATED | NCT01830348 |
| Breast reconstruction- implant + dermal sling/LD flap | Other | Approved | Breast Neoplasms | UNKNOWN | NCT02557906 |
| Breast reconstruction- autologous tissue | Other | Approved | Breast Neoplasms | UNKNOWN | NCT02557906 |
| Breast reconstruction - implant and an ADM (SurgiMend) | Other | Approved | Breast Neoplasms | UNKNOWN | NCT02557906 |
| Breast reconstruction- implant + dermal sling/LD flap | Other | Approved | Breast Neoplasms | UNKNOWN | NCT02557906 |
| Breast reconstruction- autologous tissue | Other | Approved | Breast Neoplasms | UNKNOWN | NCT02557906 |
| Breast reconstruction - implant and an ADM (SurgiMend) | Other | Approved | Breast Neoplasms | UNKNOWN | NCT02557906 |
| craniectomy | Other | Preclinical | Surgery | COMPLETED | NCT01824706 |
| Subjects undergoing TECR with ECM placement (ACell MatriStem, Boston Scientific WallFlex)) | Other | Approved | Barrett Esophagus | TERMINATED | NCT02396745 |
| Control | Other | Preclinical | Paraesophageal Hernia | COMPLETED | NCT03058731 |
| Matristem | Other | Preclinical | Paraesophageal Hernia | COMPLETED | NCT03058731 |
| Titan Modular Total Shoulder System | Other | Preclinical | Shoulder Disease | COMPLETED | NCT03956316 |
| Santyl | Other | Approved | Burns | TERMINATED | NCT02250183 |
| MEDIHONEY® GEL WITH ACTIVE LEPTOSPERMUM HONEY | Other | Approved | Burns | TERMINATED | NCT02250183 |
| Standard of Care | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT03547635 |
| A Marketed Comparator | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT03547635 |
| AMNIOEXCEL Plus Amniotic Membrane | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT03547635 |
| Integra™ dermal regeneration template | Other | Preclinical | Wounds and Injuries | UNKNOWN | NCT04543240 |
| EZ-Derm® Porcine Xenograft | Other | Approved | Partial Thickness Burn of Hand | WITHDRAWN | NCT03598023 |
| Cytal® Burn Matrix | Other | Approved | Partial Thickness Burn of Hand | WITHDRAWN | NCT03598023 |
| Cellular Dermal Replacement Tissue | Other | Approved | Foot Ulcer, Diabetic | TERMINATED | NCT01858545 |
| MatriStem | Other | Approved | Foot Ulcer, Diabetic | TERMINATED | NCT01858545 |
| Wound Sheet Matrix 2-Layer and Powder Urinary Bladder Matrix | Other | Preclinical | Pilonidal Disease | TERMINATED | NCT04041037 |
| Negative Pressure Wound Therapy | Drug | Approved | Pressure Ulcers Stage III | COMPLETED | NCT03283787 |
| MicroMatrix® and Cytal™ Wound Matrix 2-Layer plus NPWT | Other | Approved | Pressure Ulcers Stage III | COMPLETED | NCT03283787 |
| MicroMatrix® and Cytal™ Wound Matrix 2-Layer | Other | Approved | Pressure Ulcers Stage III | COMPLETED | NCT03283787 |
| ACell Arm | Other | Preclinical | Wounds | TERMINATED | NCT03632954 |
| ACell Arm | Other | Preclinical | Wounds | TERMINATED | NCT03632954 |
| Standard of Care (SOC) | Other | Approved | Diabetes | TERMINATED | NCT03626623 |
| Cytal Wound Matrix 1-Layer | Other | Approved | Diabetes | TERMINATED | NCT03626623 |
| Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend (Control) | Other | Approved | Ventral Incisional Hernia | TERMINATED | NCT03034213 |
| Gentrix™ Surgical Matrix (Treatment) | Drug | Approved | Ventral Incisional Hernia | TERMINATED | NCT03034213 |
| Mesh for hernia repair | Other | Preclinical | Ventral Incisional Hernia | TERMINATED | NCT03317665 |
| Standard of Care | Other | Approved | Diabetic Foot Ulcer | WITHDRAWN | NCT05024656 |
| AmnioExcel Plus Amniotic Membrane | Other | Approved | Diabetic Foot Ulcer | WITHDRAWN | NCT05024656 |
| Kenalog | Other | Approved | Knee Osteoarthritis | COMPLETED | NCT02767492 |
| BioD Restore | Other | Approved | Knee Osteoarthritis | COMPLETED | NCT02767492 |
| Sundt carotid shunt | Other | Preclinical | Carotid Artery Stenosis | COMPLETED | NCT03816202 |
| CODMAN CERTAS Programmable Valves | Other | Preclinical | Hydrocephalus | COMPLETED | NCT04207229 |
| CUSA Clarity Ultrasonic Surgical Aspirator System use | Other | Preclinical | Benign, Malignant Tumors or Other Soft Tissue Removal | COMPLETED | NCT04298268 |
| programmable CSF shunt valve | Other | Approved | Idiopathic Normal Pressure Hydrocephalus (INPH) | COMPLETED | NCT03350750 |
| Integra Dermal Regeneration template (IDRT) | Other | Approved | Wound Care | UNKNOWN | NCT05311124 |
| Amnio Excel + max every 2 weeks | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT04233580 |
| Amnio Excel + weekly | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT04233580 |
| CUSABT | Other | Preclinical | Cranial Skull Base Bone Removal | WITHDRAWN | NCT04300075 |
| CUSABT | Other | Preclinical | Cranial Skull Base Bone Removal | WITHDRAWN | NCT04300075 |
| MatriStem PSM | Other | Phase PHASE2 | Esophageal Adenocarcinoma | COMPLETED | NCT01970306 |
| MatriStem PSM | Other | Phase PHASE2 | Esophageal Adenocarcinoma | COMPLETED | NCT01970306 |
| Retrospective chart review | Other | Preclinical | Ventral Hernia | COMPLETED | NCT05610267 |
| Iontophoresis System With Earset | Other | Preclinical | Otitis Media | COMPLETED | NCT01611246 |
| Functional Endoscopic Sinus Surgery | Procedure | Approved | Chronic Rhinosinusitis | TERMINATED | NCT01455948 |
| Relieva Balloon Sinuplasty™ System | Other | Approved | Chronic Rhinosinusitis | TERMINATED | NCT01455948 |
| Iontophoresis System with Headset | Other | Preclinical | Anesthesia of Tympanic Membrane | COMPLETED | NCT01346332 |
| Iontophoresis System with Headset | Other | Preclinical | Anesthesia of Tympanic Membrane | COMPLETED | NCT01346332 |
| Acclarent Tympanostomy Tube Delivery System (TTDS). | Other | Approved | Otitis Media | COMPLETED | NCT02150044 |
| Acclarent Eustachian Tube Balloon Catheter (ETBC) | Other | Approved | Eustachian Tube Dysfunction | COMPLETED | NCT02087150 |
| Acclarent Eustachian Tube Balloon Catheter (ETBC) | Other | Approved | Eustachian Tube Dysfunction | COMPLETED | NCT02087150 |
| medical therapy | Drug | Approved | Recurrent Acute Rhinosinusitis | COMPLETED | NCT01714687 |
| balloon sinus dilation | Other | Approved | Recurrent Acute Rhinosinusitis | COMPLETED | NCT01714687 |
| Tympanostomy tube placement (Acclarent iontophoresis device) | Device | Approved | Otitis Media | COMPLETED | NCT01444391 |
| Tympanostomy tube placement (Acclarent iontophoresis device) | Device | Approved | Otitis Media | COMPLETED | NCT01444391 |
| Balloon Sinuplasty | Other | Approved | Chronic Sinusitis | COMPLETED | NCT00939393 |
| FESS instruments with or without balloon treatment | Drug | Approved | Chronic Sinusitis | COMPLETED | NCT00939393 |
| Tube Delivery System (TDS) | Other | Approved | Otitis Media | COMPLETED | NCT01496287 |
| Acclarent Tympanostomy Tube Delivery system (TTDS) | Other | Approved | Otitis Media | COMPLETED | NCT01324271 |
| tympanostomy tube | Other | Phase PHASE2 | Otitis Media With Effusion | COMPLETED | NCT01202578 |
| Relieva Balloon Sinuplasty System | Other | Preclinical | Sinusitis | COMPLETED | NCT01107379 |
| Ethmoid Sinus Spacer | Other | Approved | Sinusitis, Chronic Rhinosinusitis | TERMINATED | NCT01054703 |
| Ethmoid Sinus Spacer | Other | Approved | Sinusitis, Chronic Rhinosinusitis | TERMINATED | NCT01054703 |
| Tympanostomy Tube Delivery System | Other | Approved | Otitis Media | COMPLETED | NCT01046877 |
| Acclarent Tympanostomy Tube Delivery System | Other | Approved | Otitis Media With Effusion | COMPLETED | NCT00939796 |
| Stratus Microflow Ethmoid Spacer | Other | Approved | Sinusitis | COMPLETED | NCT00791934 |
| Sinuplasty | Other | Phase PHASE3 | Chronic Sinusitis | COMPLETED | NCT00231062 |
| CUSA (Cavitronic Ultrasonic Surgical Aspirator) | Other | Preclinical | Vulvar Intraepithelial Neoplasia | COMPLETED | NCT06297187 |
| antibiotic-impregnated catheter | Other | Preclinical | Hydrocephalus | RECRUITING | NCT06276543 |
| antibiotic-impregnated catheter | Other | Preclinical | Hydrocephalus | RECRUITING | NCT06276543 |
| SurgiMend PRS | Other | Preclinical | Reconstructive Surgical Procedures | COMPLETED | NCT05182177 |
| Integra® Gentrix® Surgical Matrix | Other | Preclinical | Hernia | COMPLETED | NCT06034652 |
| Robot-Assisted Radical Prostatectomy | Other | Phase PHASE2 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT05842057 |
| BioDFence G3 Placental Tissue Membrane | Other | Phase PHASE2 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT05842057 |
| CerebroFlo™ EVD Catheter | Other | Approved | Intraventricular Hemorrhage | COMPLETED | NCT05113381 |
| intracranial pressure monitoring | Other | Preclinical | Intracranial Hypertension | RECRUITING | NCT04459806 |
| intracranial pressure monitoring | Other | Preclinical | Intracranial Hypertension | RECRUITING | NCT04459806 |
| External Ventricular Drainage (EVD) | Other | Preclinical | Cerebrospinal; Disorder | COMPLETED | NCT05652296 |
| Aurora Surgiscope System | Other | Preclinical | Supratentorial Hemorrhage | RECRUITING | NCT04494295 |
| Aurora Surgiscope System | Other | Preclinical | Supratentorial Hemorrhage | RECRUITING | NCT04494295 |
| CODMAN CERTAS Plus Programmable Valve | Other | Preclinical | Hydrocephalus | ACTIVE_NOT_RECRUITING | NCT05397106 |
| CODMAN CERTAS Plus Programmable Valve | Other | Preclinical | Hydrocephalus | ACTIVE_NOT_RECRUITING | NCT05397106 |
| CODMAN CERTAS Plus Programmable Valve | Other | Preclinical | Hydrocephalus | ACTIVE_NOT_RECRUITING | NCT05397106 |
| Cytal® Wound Matrix 2-Layer | Other | Approved | Pressure Injury | COMPLETED | NCT06629506 |
| MicroMatrix® UBM Particulate | Other | Approved | Pressure Injury | COMPLETED | NCT06629506 |
| MicroMatrix® Flex | Other | Approved | Pressure Injury | COMPLETED | NCT06629506 |
| Cytal® Wound Matrix 2-Layer | Other | Approved | Pressure Injury | COMPLETED | NCT06629506 |
| MicroMatrix® UBM Particulate | Other | Approved | Pressure Injury | COMPLETED | NCT06629506 |
| MicroMatrix® Flex | Other | Approved | Pressure Injury | COMPLETED | NCT06629506 |
| Standard of Care | Other | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| AmnioExcel Plus for Diabetic Foot Ulcers | Other | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| AmnioExcel Plus for Venous Leg Ulcers | Other | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers | Device | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers | Device | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| SurgiMend Mesh | Other | Approved | Hiatal Hernia | COMPLETED | NCT04282720 |
| SurgiMend Mesh | Other | Approved | Hiatal Hernia | COMPLETED | NCT04282720 |
| SurgiMend Mesh | Other | Approved | Hiatal Hernia | COMPLETED | NCT04282720 |
| SurgiMend Mesh | Other | Approved | Hiatal Hernia | COMPLETED | NCT04282720 |
| Standard of Care | Other | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| AmnioExcel Plus for Diabetic Foot Ulcers | Other | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| AmnioExcel Plus for Venous Leg Ulcers | Other | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers | Device | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
| Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers | Device | Approved | Diabetic Foot Ulcer | ENROLLING_BY_INVITATION | NCT06453187 |
Total products: 149